Global Cushing

  • receipt Report ID : 30155
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 92
  • list Pharmaceuticals and Healthcare

Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands.

Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals. Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.

In 2020, the global Cushing’s Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Cushing’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cushing’s Disease Treatment development in United States, Europe and China.

The key players covered in this study

CORCEPT THERAPEUTICS

HRA Pharma

Strongbridge Biopharma

Novartis

...

Market segment by Type, the product can be split into

Ketoconazole

Mitotane

Aminoglutethimide

Metyrapone

Mifepristone

Etomidate

Pasireotide

Market segment by Application, split into

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Clinics

E-Commerce/Online Pharmacies 

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Cushing’s Disease Treatment status, future forecast, growth opportunity, key market and key players.

To present the Cushing’s Disease Treatment development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cushing’s Disease Treatment are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Cushing’s Disease Treatment Market Size Growth Rate by Type (2015-2026)

1.4.2 Ketoconazole

1.4.3 Mitotane

1.4.4 Aminoglutethimide

1.4.5 Metyrapone

1.4.6 Mifepristone

1.4.7 Etomidate

1.4.8 Pasireotide

1.5 Market by Application

1.5.1 Global Cushing’s Disease Treatment Market Share by Application (2015-2026)

1.5.2 Hospital Pharmacies

1.5.3 Retail Pharmacies

1.5.4 Drug Stores

1.5.5 Clinics

1.5.6 E-Commerce/Online Pharmacies 

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Cushing’s Disease Treatment Market Size

2.2 Cushing’s Disease Treatment Growth Trends by Regions

2.2.1 Cushing’s Disease Treatment Market Size by Regions (2015-2026)

2.2.2 Cushing’s Disease Treatment Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Cushing’s Disease Treatment Market Size by Manufacturers

3.1.1 Global Cushing’s Disease Treatment Revenue by Manufacturers (2015-2020)

3.1.2 Global Cushing’s Disease Treatment Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Cushing’s Disease Treatment Market Concentration Ratio (CR5 and HHI)

3.2 Cushing’s Disease Treatment Key Players Head office and Area Served

3.3 Key Players Cushing’s Disease Treatment Product/Solution/Service

3.4 Date of Enter into Cushing’s Disease Treatment Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Cushing’s Disease Treatment Market Size by Type (2015-2020)

4.2 Global Cushing’s Disease Treatment Market Size by Application (2015-2020)

5 United States

5.1 United States Cushing’s Disease Treatment Market Size (2015-2020)

5.2 Cushing’s Disease Treatment Key Players in United States

5.3 United States Cushing’s Disease Treatment Market Size by Type

5.4 United States Cushing’s Disease Treatment Market Size by Application

6 Europe

6.1 Europe Cushing’s Disease Treatment Market Size (2015-2020)

6.2 Cushing’s Disease Treatment Key Players in Europe

6.3 Europe Cushing’s Disease Treatment Market Size by Type

6.4 Europe Cushing’s Disease Treatment Market Size by Application

7 China

7.1 China Cushing’s Disease Treatment Market Size (2015-2020)

7.2 Cushing’s Disease Treatment Key Players in China

7.3 China Cushing’s Disease Treatment Market Size by Type

7.4 China Cushing’s Disease Treatment Market Size by Application

8 Japan

8.1 Japan Cushing’s Disease Treatment Market Size (2015-2020)

8.2 Cushing’s Disease Treatment Key Players in Japan

8.3 Japan Cushing’s Disease Treatment Market Size by Type

8.4 Japan Cushing’s Disease Treatment Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Cushing’s Disease Treatment Market Size (2015-2020)

9.2 Cushing’s Disease Treatment Key Players in Southeast Asia

9.3 Southeast Asia Cushing’s Disease Treatment Market Size by Type

9.4 Southeast Asia Cushing’s Disease Treatment Market Size by Application

10 India

10.1 India Cushing’s Disease Treatment Market Size (2015-2020)

10.2 Cushing’s Disease Treatment Key Players in India

10.3 India Cushing’s Disease Treatment Market Size by Type

10.4 India Cushing’s Disease Treatment Market Size by Application

11 Central & South America

11.1 Central & South America Cushing’s Disease Treatment Market Size (2015-2020)

11.2 Cushing’s Disease Treatment Key Players in Central & South America

11.3 Central & South America Cushing’s Disease Treatment Market Size by Type

11.4 Central & South America Cushing’s Disease Treatment Market Size by Application

12 International Players Profiles

12.1 CORCEPT THERAPEUTICS

12.1.1 CORCEPT THERAPEUTICS Company Details

12.1.2 Company Description and Business Overview

12.1.3 Cushing’s Disease Treatment Introduction

12.1.4 CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2015-2020)

12.1.5 CORCEPT THERAPEUTICS Recent Development

12.2 HRA Pharma

12.2.1 HRA Pharma Company Details

12.2.2 Company Description and Business Overview

12.2.3 Cushing’s Disease Treatment Introduction

12.2.4 HRA Pharma Revenue in Cushing’s Disease Treatment Business (2015-2020)

12.2.5 HRA Pharma Recent Development

12.3 Strongbridge Biopharma

12.3.1 Strongbridge Biopharma Company Details

12.3.2 Company Description and Business Overview

12.3.3 Cushing’s Disease Treatment Introduction

12.3.4 Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2015-2020)

12.3.5 Strongbridge Biopharma Recent Development

12.4 Novartis

12.4.1 Novartis Company Details

12.4.2 Company Description and Business Overview

12.4.3 Cushing’s Disease Treatment Introduction

12.4.4 Novartis Revenue in Cushing’s Disease Treatment Business (2015-2020)

12.4.5 Novartis Recent Development

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Cushing’s Disease Treatment Key Market Segments

Table Key Players Cushing’s Disease Treatment Covered

Table Global Cushing’s Disease Treatment Marke